No abstract available
Publication types
-
Comment
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Benzamides
-
Disease-Free Survival
-
Hematopoietic Stem Cell Transplantation* / mortality
-
Humans
-
Imatinib Mesylate
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / mortality
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
-
Piperazines / therapeutic use*
-
Protein Kinase Inhibitors / therapeutic use*
-
Pyrimidines / therapeutic use*
-
Survival Rate
Substances
-
Benzamides
-
Piperazines
-
Protein Kinase Inhibitors
-
Pyrimidines
-
Imatinib Mesylate